Company intelligence / Profile preview

RestorEar Devices

Miami, Florida, United Statesrestorear.com ↗

Ownership: Private
Development stage: Other

Overview

RestorEar Devices has developed ReBound, a research-backed home-use and clinical device using cold therapy to reduce the impact of noise exposure on hearing. The company is running a Phase II human clinical trial in collaboration with the University of Miami to test efficacy in firefighters. Their consumer product is FDA registered as a Class 1 medical device and supported by NIH funding.

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapy (cold therapy/therapeutic hypothermia)
Industry: Therapeutic Medical Devices

Partnerships

University of Miami School of Medicine/Department of Otolaryngology

Beyond the preview

Go deeper on RestorEar Devices.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RestorEar Devices.

Explore the full profile